Allogeneic hematopoietic stem cell transplantati... Hideaki,Kawada,Makoto,... - 《Biology of Blood & Marrow Transplantation》 被引量: 9发表: 2015年 Autologous stem cell transplantation for lymphoma in HIV+ patients: higher rate of infections compared with non-HIV lymphoma Autologous hematopoietic ...
Indolent lymphomaAllogeneic transplantConditioning regimensDonor typeAllogeneic transplantation is established as a curative treatment for follicular lymphoma, but with considerable short and long-term morbidity and mortality. Data and controversies regarding conditioning regimen, donor source, GVHD prophylaxis, ...
But not everyone shares this view. Survival curves in similar blood cancers, such as leukaemia and lymphoma, level out over time — the hallmark of a cure in the cancer field. This doesn't happen in patients undergoing treatment for multiple myeloma. So Rajkumar argues that some myeloma resear...
Stem cell transplantationhas potential in many different areas of health and medical research. Advanced facilities for stem cell therapy, as well as effective and reasonable guidelines and strategies for stemcell transplantin different regions are of great importance for the realization and enhancement of...
wider use of cell selection, have contributed to a significant reduction in the morbidity and mortality associated with conventional transplantation. HDC with transplant is now standard therapy in multiple myeloma, acute myeloid leukemia in first remission, and intermediate-grade non-Hodgkin's lymphoma....
Rituximab: enhancing stem cell transplan- tation in mantle cell lymphoma. Bone Marrow Transplant 2002;29(Suppl 1):S10-3.Gianni, A., Cortelazzo, S., Magni, M. & Martelli, M. (2002) Rituximab: enhancing stem cell transplantation in mantle cell lymphoma; Michelangelo Cooperative. Bone Marrow ...
celltransplantationclinicaltrialsMantle cell lymphoma (MCL) is an aggressive form of non‐Hodgkin lymphoma that remains incurable for the majority of patients. Allogeneic stem cell transplantation (alloSCT) produces long‐term disease‐free remissions for around 30–40% patients, however it is reserved...
An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a h... The role of allogeneic bone marrow transplantation in remains uncertain. We have analyzed 1185 allogeneic transplants for reported to the EBM...
Conclusions: Treatment of allo-HSCT was an effective radical cure for NK/T-cell lymphoma,and local radiotherapy and donor lymphocyte infusion were used to prevent relapse post-transplant. 展开 关键词: NK/T-cell lymphoma Allogeneic Hematopoietic stem cell transplantation Radiotherapy Donor lymphocyte in...
Theode Witte, inClinical Lymphoma Myeloma and Leukemia, 2011 Allogeneic stem cell transplantation(SCT) is the treatment of choice for young patients (age ≤ 55 years) withmyelodysplastic syndromes(MDS) characterized by poor-risk or intermediate-risk cytogenetics, who have a histocompatible related or...